Del. Justices Spike EpicentRx Appeal For Target Co. Docs
Clinical-stage biopharma company EpicentRx Inc. may not revive its books and records suit against potential acquisition target Prothex Inc., Delaware's Supreme Court said in an order Thursday, upholding several Chancery Court...To view the full article, register now.
Already a subscriber? Click here to view full article